Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 212514
Company: SPIL
Company: SPIL
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
AMPHOTERICIN B | AMPHOTERICIN B | 50MG/VIAL | INJECTABLE, LIPOSOMAL;INJECTION | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
12/14/2021 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/212514Orig1s000ltr.pdf |
AMPHOTERICIN B
INJECTABLE, LIPOSOMAL;INJECTION; 50MG/VIAL
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
AMBISOME | AMPHOTERICIN B | 50MG/VIAL | INJECTABLE, LIPOSOMAL;INJECTION | Prescription | Yes | AB | 050740 | ASTELLAS |
AMPHOTERICIN B | AMPHOTERICIN B | 50MG/VIAL | INJECTABLE, LIPOSOMAL;INJECTION | Prescription | No | AB | 214010 | EUGIA PHARMA |
AMPHOTERICIN B | AMPHOTERICIN B | 50MG/VIAL | INJECTABLE, LIPOSOMAL;INJECTION | Prescription | No | AB | 212514 | SPIL |